{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Durability of engraftment is defined as the duration and stability of hematopoiesis following autologous transplantation. Subjects who experience durable engraftment have neutrophil counts greater than 500 and platelet counts greater than 20,000 within the specified time frame.","groups":[{"description":"Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \\<20 cells/ul)following 5 days of G-CSF mobilization.","id":"OG000","title":"G-CSF Plus Plerixafor"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"12 months","title":"Number of Subjects Experiencing Durability of Engraftment","type":"SECONDARY","unitOfMeasure":"participants"}